Skip to main content
. 2017 Apr 21;8(27):44131–44140. doi: 10.18632/oncotarget.17311

Table 1. Patient characteristics.

Patient 1 2 3 4 5 6 7 8 9 10
Age (yr) 79 55 77 76 67 53 60 71 46 82
Date of RP Mar 2014 Mar 2014 Mar 2015 Feb 2014 Jun 2013 Oct 2013 Sep 2012 Aug 2013 Oct 2013 Nov 2014
Histopathology pT3b pN1 (1/24) cM1b R1 pT3b pN1 (4/8) cM1b R0 pT3b pN0 (0/27) cM1b R1 pT3b pN1 (6/6) cM1b R1 pT3b pN1 (1/9) cM1b R1 pT3b pN1 (4/18) cM1b R1 pT3a pN0 (0/21) cM1b R0 pT3b pN1 (2/11) cM1b R1 pT3b pN1 (5/29) cM1b R1 pT3b pN1 (1/4) cM1b R1
Gleason score 9 (5+4) 8 (5+3) 9 (4+5) 9 (4+5) 10 (5+5) 9 (4+5) 9 (4+5) 9 (5+4) 10 (5+5) 9 (5+4)
PSA at diagnosis (ng/mL) 4.6 186 694 117 43.5 289 17 7278 18.4 23

RP = Radical prostatectomy; PSA = Prostate-specific antigen.